The effects of oral contraceptives on detection and pain thresholds as well as headache intensity during menstrual cycle in migraine

Headache

Volumn 51, Issue 1, 2011, Pages 92-104

  Teepker, Michael ^a   Peters, Mira ^b   Kundermann, Bernd ^a   Vedder, Helmut ^a   Schepelmann, Karsten ^a   Lautenbacher, Stefan ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF BAMBERG   (Germany)

Author keywords

experimental pain; headache intensity; menstrual cycle; migraine; oral contraceptive; pain and detection threshold

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COLD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; ELECTRIC CURRENT; FEMALE; HEADACHE; HEAT; HUMAN; MENSTRUAL CYCLE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PAIN ASSESSMENT; PAIN THRESHOLD; PRESSURE; PRIORITY JOURNAL; QUESTIONNAIRE; SALIVA LEVEL; SELF REPORT;

ADULT; ANALYSIS OF VARIANCE; CONTRACEPTIVE AGENTS, FEMALE; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MENSTRUAL CYCLE; MIGRAINE DISORDERS; PAIN MEASUREMENT; PAIN THRESHOLD; SALIVA;

EID: 78650935559     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01775.x     Document Type: Article

References (37)

1. Silberstein SD, Merriam GR,. Estrogens, progestins, and headache. Neurology. 1991; 41: 786-793.
2. Silberstein SD, Merriam GR,. Sex hormones and headache. J Pain Symptom Manage. 1993; 8: 98-114.
3. LeResche L, Mancl L, Sherman JJ, et al. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain. 2003; 106: 253-261.
4. Locker D, Slade G,. Prevalence of symptoms associated with temporomandibular disorders in a Canadian population. Community Dent Oral Epidemiol. 1988; 16: 310-313.
5. Lipton RB, Silberstein SD, Stewart WF,. An update on the epidemiology of migraine. Headache. 1994; 34: 319-328.
6. Rasmussen BK,. Epidemiology of headache. Cephalalgia. 1995; 15: 45-68.
7. Kudrow L,. The relationship of headache frequency to hormone use in migraine. Headache. 1975; 15: 36-40.
8. Dao TT, Knight K, Ton-That V,. Modulation of myofascial pain by the reproductive hormones: A preliminary report. J Prosthet Dent. 1998; 79: 663-670.
9. Vignolo V, Vedolin GM, de Araujo CDRP, et al. Influence of the menstrual cycle on the pressure pain threshold of masticatory muscles in patients with masticatory myofascial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: 308-315.
10. Bragdon EE, Light KC, Costello NL, et al. Group differences in pain modulation: Pain-free women compared to pain-free men and to women with TMD. Pain. 2002; 96: 227-237.
11. Tedford W, Warren D, Flynn W,. Alteration of shock aversion thresholds during the menstrual cycle. Percept Psychophys. 1977; 21: 21-34.
12. Drobek W, Schoenaers J, De Laat A,. Hormone-dependent fluctuations of pressure pain threshold and tactile threshold of the temporalis and masseter muscle. J Oral Rehabil. 2002; 29: 1042-1051.
13. Veith JL, Anderson J, Slade SA, et al. Plasma beta-endorphin, pain thresholds and anxiety levels across the human menstrual cycle. Physiol Behav. 1984; 32: 31-34.
14. Hapidou EG, Rollman GB,. Menstrual cycle modulation of tender points. Pain. 1998; 77: 151-161.
15. Dawson-Basoa M, Gintzler AR,. Gestational and ovarian sex steroid antinociception: Synergy between spinal kappa and delta opioid systems. Brain Res. 1998; 794: 61-67.
16. Smith LJ, Henderson JA, Abell CW, et al. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology. 2004; 29: 2035-2045.
17. Herzog AG,. Neuroactive properties of reproductive steroids. Headache. 2007; 47 (Suppl. 2): S68-S78.
18. Puri V, Puri S, Svojanovsky SR, et al. Effects of oestrogen on trigeminal ganglia in culture: Implications for hormonal effects on migraine. Cephalalgia. 2006; 26: 33-42.
19. Imthurn B, Rosselli M, Jaeger AW, et al. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. J Clin Endocrinol Metab. 1997; 82: 388-394.
20. Ramsay B, Johnson MR, Leone AM, et al. The effect of exogenous oestrogen on nitric oxide production in women: A placebo controlled crossover study. Br J Obstet Gynaecol. 1995; 102: 417-419.
21. Olesen J, Jansen-Olesen I,. Nitric oxide mechanisms in migraine. Pathol Biol (Paris). 2000; 48: 648-657.
22. Neeb L, Reuter U,. Nitric oxide in migraine. CNS Neurol Disord Drug Targets. 2007; 6: 258-264.
23. Srikiatkhachorn A, Suwattanasophon C, Ruangpattanatawee U, et al. 2002 Wolff Award. 5-HT2A receptor activation and nitric oxide synthesis: A possible mechanism determining migraine attacks. Headache. 2002; 42: 566-574.
24. MacGregor EA, Frith A, Ellis J, et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006; 67: 2154-2158.
25. Afra J,. Cortical excitability in migraine. J Headache Pain. 2000; 2: 73-81.
26. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol. 2000; 47: 614-624.
27. Headache Classification Committee of the International Headache Society. The International Classification of the Headache Disorders, 2nd edition. Cephalalgia. 2004; 24: 1-160.
28. Margraf J,. Margraf J: Mini-DIPS. Diagnostisches Kurz-Interview Bei Psychischen Störungen. Berlin: Springer; 1994.
29. Sherman JJ, LeResche L, Mancl LA, et al. Cyclic effects on experimental pain response in women with temporomandibular disorders. J Orofac Pain. 2005; 19: 133-143.
30. Kuba T, Wu HK, Nazarian A, et al. Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats. Horm Behav. 2006; 49: 441-449.
31. Pielsticker A, Lautenbacher S,. Disturbances of Pain Perception in Primary Headache: Migraine, Tension-Type, and Cluster Headache. New York: Kluwer Academic/Plenum; 2004.
32. Burstein R, Cutrer MF, Yarnitsky D,. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000; 123: 1703-1709.
33. Kitaj MB, Klink M,. Pain thresholds in daily transformed migraine versus episodic migraine headache patients. Headache. 2005; 45: 992-998.
34. Domingues RB, Fonseca KB, Ziviane LF, et al. Altered cardiovascular reactivity to mental stress but not to cold pressure test in migraine. Headache. 2010; 50: 133-137.
35. Teepker M, Peters M, Vedder H, et al. Menstrual variation in experimental pain: Correlation with gonadal hormones. Neuropsychobiology. 2010; 61: 131-140.
36. Hofman LF,. Human saliva as a diagnostic specimen. J Nutr. 2001; 131: 1621S-1625S.
37. Epstein MT, Hockaday JM, Hockaday TD,. Migraine and reproductive hormones throughout the menstrual cycle. Lancet. 1975; 1: 543-548.